KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential [Yahoo! Finance]
Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases [Yahoo! Finance]
Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock [Yahoo! Finance]
Kodiak Sciences Inc. (NASDAQ: KOD) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.